This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CTI BioPharma Corporation
Drug Names(s): PG-CPT, polyglutamate-camptothecin
Description: CT-2106 is a novel polyglutamate-camptothecin. It is water soluble, and preclinical studies suggest that it permits up to 400% more drug to be administered without an increase in toxicity. CT-2106 as a single agent and/or in combination with 5FU showed significantly enhanced anti-tumor activity in several animal tumor models.
Additional information available to subscribers only: